{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:32:27Z","timestamp":1784302347357,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174530"],"award-info":[{"award-number":["82174530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.joim.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:29:10Z","timestamp":1698557350000},"page":"528-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blinding assessment in clinical trials of traditional Chinese medicine: Exploratory principles and protocol"],"prefix":"10.1016","volume":"21","author":[{"given":"Xiao-cong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-le","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-gang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-fan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9307","key":"10.1016\/j.joim.2023.10.003_b0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.joim.2023.10.003_b0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hr\u00f3bjartsson","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"7848","key":"10.1016\/j.joim.2023.10.003_b0015","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1136\/bmj.e1119","article-title":"Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"344","author":"Hr\u00f3bjartsson","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.joim.2023.10.003_b0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ije\/dyt270","article-title":"Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"43","author":"Hr\u00f3bjartsson","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.joim.2023.10.003_b0025","first-page":"1038","article-title":"Ascorbic acid for the common cold","volume":"231","author":"Karlowski","year":"1975","journal-title":"A prophylactic and therapeutic trial. JAMA"},{"issue":"9","key":"10.1016\/j.joim.2023.10.003_b0030","doi-asserted-by":"crossref","first-page":"e1003294","DOI":"10.1371\/journal.pmed.1003294","article-title":"TIDieR-Placebo: A guide and checklist for reporting placebo and sham controls","volume":"17","author":"Howick","year":"2020","journal-title":"PLoS Med"},{"issue":"9721","key":"10.1016\/j.joim.2023.10.003_b0035","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(10)60413-8","article-title":"CONSORT 2010 changes and testing blindness in RCTs","volume":"375","author":"Schulz","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.joim.2023.10.003_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.curtheres.2010.02.001","article-title":"The reporting quality, scientific rigor, and ethics of randomized placebo-controlled trials of traditional Chinese medicine compound formulations and the differences between Chinese and non-Chinese trials","volume":"71","author":"Zhong","year":"2010","journal-title":"Curr Ther Res Clin Exp"},{"issue":"10","key":"10.1016\/j.joim.2023.10.003_b0045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jclinepi.2014.05.007","article-title":"The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications","volume":"67","author":"Bello","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.joim.2023.10.003_b0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jclinepi.2021.02.022","article-title":"Measuring the success of blinding in placebo-controlled trials: should we be so quick to dismiss it?","volume":"135","author":"Webster","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.joim.2023.10.003_b0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11684-020-0801-x","article-title":"The role played by traditional Chinese medicine in preventing and treating COVID-19 in China","volume":"14","author":"Li","year":"2020","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.joim.2023.10.003_b0060","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S1474-4422(16)00066-1","article-title":"Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects","volume":"15","author":"Benedetti","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.joim.2023.10.003_b0065","doi-asserted-by":"crossref","unstructured":"Franklin B, Majault, le Roy, Sallin, Bailly JS, d\u2019Arcet, et al. Report of the commissioners charged by the King with the examination of the animal magnetism. Int J Clin Exp Hypn 2002; 50(4): 332-63.","DOI":"10.1080\/00207140208410109"},{"key":"10.1016\/j.joim.2023.10.003_b0070","first-page":"284","article-title":"\u00dcber Behandlung der Diphtherie mit gew\u00f6hnlichem Pferdeserum","volume":"125","author":"Bingel","year":"1918","journal-title":"Dtsch Arch Klin Med"},{"issue":"1","key":"10.1016\/j.joim.2023.10.003_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF01568704","article-title":"On a methodology for the clinical evaluation of phrenopraxic drugs","volume":"31","author":"Sainz","year":"1957","journal-title":"Psychiatr Q"},{"issue":"24","key":"10.1016\/j.joim.2023.10.003_b0080","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.1994.03520240054041","article-title":"A proposal for structured reporting of randomized controlled trials","volume":"272","author":"Andrew","year":"1994","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.joim.2023.10.003_b0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: the CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.joim.2023.10.003_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.joim.2023.10.003_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2020.100632","article-title":"A pre-trial evaluation of blinding for a Chinese herbal medicine trial","volume":"19","author":"Razavy","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.joim.2023.10.003_b0100","unstructured":"Ji CH, Cao Y, Chen J, Zhang Y, Liu S, Li QS. A blind technique used in randomized controlled trials of treatment based on changes of syndromes. Zhongguo Zhong Xi Yi Jie He Za Zhi 2014; 34(7): 869\u201372 [Chinese with abstract in English]."},{"key":"10.1016\/j.joim.2023.10.003_b0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12906-019-2722-2","article-title":"Placebo design in WHO-registered trials of Chinese herbal medicine need improvements","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Complement Altern Med"},{"issue":"2 Suppl","key":"10.1016\/j.joim.2023.10.003_b0110","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.jfda.2018.02.004","article-title":"Effects of processing adjuvants on traditional Chinese herbs","volume":"26","author":"Chen","year":"2018","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.joim.2023.10.003_b0115","unstructured":"Tang XD, Bian LQ, Gao R. Exploration into the preparation of placebos used in Chinese medicinal clinical trial. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009; 29(7): 656\u20138 [Chinese with abstract in English]."},{"issue":"2","key":"10.1016\/j.joim.2023.10.003_b0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0964528420924035","article-title":"Establishment of appropriate sham acupuncture and successful patient blinding","volume":"39","author":"Hu","year":"2021","journal-title":"Acupunct Med"},{"key":"10.1016\/j.joim.2023.10.003_b0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ctcp.2019.09.004","article-title":"Factors influencing the quality of clinical trials on traditional Chinese medicine\u2014qualitative interviews with trial auditors, clinicians and academic researchers","volume":"37","author":"Han","year":"2019","journal-title":"Complement Ther Clin Pract"},{"issue":"12","key":"10.1016\/j.joim.2023.10.003_b0130","first-page":"1159","article-title":"Principles, difficulties and evaluation of blinding in clinical trials of traditional Chinese medicine","volume":"37","author":"Zhang","year":"2018","journal-title":"Beijing Zhong Yi Yao"},{"issue":"Suppl 1","key":"10.1016\/j.joim.2023.10.003_b0135","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ctim.2010.12.002","article-title":"Non-penetrating sham needle, is it an adequate sham control in acupuncture research?","volume":"19","author":"Lee","year":"2011","journal-title":"Complement Ther Med"},{"issue":"8","key":"10.1016\/j.joim.2023.10.003_b0140","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.joim.2023.10.003_b0145","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/(SICI)1097-0258(19960715)15:13<1421::AID-SIM266>3.0.CO;2-H","article-title":"An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation\u2014a VA cooperative study","volume":"15","author":"James","year":"1996","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.joim.2023.10.003_b0150","first-page":"1163","article-title":"Evaluation and thinking of simulation effect of placebo on new drug clinical trials of traditional Chinese medicines","volume":"18","author":"Lu","year":"2018","journal-title":"Zhongguo Xun Zheng Yi Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.joim.2023.10.003_b0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1600-0528.2009.00494.x","article-title":"Towards a proposal for assessment of blinding success in clinical trials: up-to-date review","volume":"37","author":"Kolahi","year":"2009","journal-title":"Community Dent Oral Epidemiol"},{"issue":"3","key":"10.1016\/j.joim.2023.10.003_b0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000346144","article-title":"Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000\u20132010","volume":"82","author":"Baethge","year":"2013","journal-title":"Psychother Psychosom"},{"issue":"2","key":"10.1016\/j.joim.2023.10.003_b0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cct.2003.10.016","article-title":"Assessment of blinding in clinical trials","volume":"25","author":"Bang","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.joim.2023.10.003_b0170","article-title":"Similarity evaluation on the compound TCM formulation \u201cHuoling Shengji Granule\u201d and its placebo by intelligent sensory evaluation technologies and the human sensory evaluation method based on critical quality attributes","volume":"2021","author":"Wu","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.joim.2023.10.003_b0175","unstructured":"Wu F, Lu ZQ, Hu JL. Wu M, Feng Y, Zhang JQ, et al. Design and quality control of traditional Chinese medicine formula placebo for the clinical trials. Zhongguo Xin Yao Za Zhi 2018; 27(11): 1254\u201361 [Chinese with abstract in English]."},{"issue":"1","key":"10.1016\/j.joim.2023.10.003_b0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/00031305.1987.10475440","article-title":"Sample size for estimating multinomial proportions","volume":"41","author":"Thompson","year":"1987","journal-title":"Am Stat"},{"issue":"5","key":"10.1016\/j.joim.2023.10.003_b0185","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/10543406.2017.1399898","article-title":"Sample size calculations for blinding assessment","volume":"28","author":"Landsman","year":"2018","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.joim.2023.10.003_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.673729","article-title":"Developing placebos for clinical research in traditional Chinese medicine: assessing organoleptic properties of three dosage forms (oral liquid, capsule and granule)","volume":"12","author":"Xiao","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.joim.2023.10.003_b0195","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7326\/0003-4819-136-3-200202050-00022","article-title":"The landscape and lexicon of blinding in randomized trials","volume":"136","author":"Schulz","year":"2002","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.joim.2023.10.003_b0200","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archpsyc.1997.01830200078011","article-title":"Double-blindness procedures, rater blindness, and ratings of outcome. Observations from a controlled trial","volume":"54","author":"Ba\u015fo\u011flu","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.joim.2023.10.003_b0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1745-6215-13-189","article-title":"Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex\u00ae) in people with multiple sclerosis: a new approach","volume":"13","author":"Wright","year":"2012","journal-title":"Trials"},{"issue":"7448","key":"10.1016\/j.joim.2023.10.003_b0210","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bmj.328.7448.1135-b","article-title":"Turning a blind eye: Authors have blinkered view of blinding","volume":"328","author":"Senn","year":"2004","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.joim.2023.10.003_b0215","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1001\/archinte.165.17.2026","article-title":"Acupuncture for subacute stroke rehabilitation: a sham-controlled, subject- and assessor-blind, randomized trial","volume":"165","author":"Park","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.joim.2023.10.003_b0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.conctc.2016.05.003","article-title":"Random guess and wishful thinking are the best blinding scenarios","volume":"3","author":"Bang","year":"2016","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.joim.2023.10.003_b0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2016.08.002","article-title":"Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials","volume":"81","author":"Bello","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496423000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496423000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:54:52Z","timestamp":1761864892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496423000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2095496423000808"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2023.10.003","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blinding assessment in clinical trials of traditional Chinese medicine: Exploratory principles and protocol","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}